{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:25:19Z","timestamp":1783607119245,"version":"3.55.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1038\/s41401-025-01504-y","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T08:10:50Z","timestamp":1740989450000},"page":"1852-1863","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Intracerebellar upregulation of Rheb(S16H) ameliorates motor dysfunction in mice with SCA2"],"prefix":"10.1038","volume":"46","author":[{"given":"Sehwan","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwoo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyemi","family":"Eo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gi Beom","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Min","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minsang","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngpyo","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Ryong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,3]]},"reference":[{"key":"1504_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-019-0074-3","volume":"5","author":"T Klockgether","year":"2019","unstructured":"Klockgether T, Mariotti C, Paulson HL. Spinocerebellar ataxia. Nat Rev Dis Primers. 2019;5:24.","journal-title":"Nat Rev Dis Primers"},{"key":"1504_CR2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S1474-4422(04)00737-9","volume":"3","author":"L Schols","year":"2004","unstructured":"Schols L, Bauer P, Schmidt T, Schulte T, Riess O. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol. 2004;3:291\u2013304.","journal-title":"Lancet Neurol"},{"key":"1504_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-012-1000-x","volume":"124","author":"K Seidel","year":"2012","unstructured":"Seidel K, Siswanto S, Brunt ER, den Dunnen W, Korf HW, Rub U. Brain pathology of spinocerebellar ataxias. Acta Neuropathol. 2012;124:1\u201321.","journal-title":"Acta Neuropathol"},{"key":"1504_CR4","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/B978-0-444-51892-7.00026-7","volume":"103","author":"GW Auburger","year":"2012","unstructured":"Auburger GW. Spinocerebellar ataxia type 2. Handb Clin Neurol. 2012;103:423\u201336.","journal-title":"Handb Clin Neurol"},{"key":"1504_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clinph.2021.12.005","volume":"135","author":"L Velazquez-Perez","year":"2022","unstructured":"Velazquez-Perez L, Rodriguez-Labrada R, Gonzalez-Garces Y, Vazquez-Mojena Y, Perez-Rodriguez R, Ziemann U. Neurophysiological features in spinocerebellar ataxia type 2: Prospects for novel biomarkers. Clin Neurophysiol. 2022;135:1\u201312.","journal-title":"Clin Neurophysiol"},{"key":"1504_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/978-3-319-71779-1_8","volume":"1049","author":"DR Scoles","year":"2018","unstructured":"Scoles DR, Pulst SM. Spinocerebellar ataxia type 2. Adv Exp Med Biol. 2018;1049:175\u201395.","journal-title":"Adv Exp Med Biol"},{"key":"1504_CR7","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3389\/fnins.2016.00572","volume":"10","author":"JM Alves-Cruzeiro","year":"2016","unstructured":"Alves-Cruzeiro JM, Mendonca L, Pereira de Almeida L, Nobrega C. Motor dysfunctions and neuropathology in mouse models of spinocerebellar ataxia type 2: a comprehensive review. Front Neurosci. 2016;10:572.","journal-title":"Front Neurosci"},{"key":"1504_CR8","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S1474-4422(15)00201-X","volume":"14","author":"S Romano","year":"2015","unstructured":"Romano S, Coarelli G, Marcotulli C, Leonardi L, Piccolo F, Spadaro M, et al. Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2015;14:985\u201391.","journal-title":"Lancet Neurol"},{"key":"1504_CR9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00415-014-7551-0","volume":"262","author":"F Sacca","year":"2015","unstructured":"Sacca F, Puorro G, Brunetti A, Capasso G, Cervo A, Cocozza S, et al. A randomized controlled pilot trial of lithium in spinocerebellar ataxia type 2. J Neurol. 2015;262:149\u201353.","journal-title":"J Neurol"},{"key":"1504_CR10","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s12311-012-0382-6","volume":"11","author":"L Velazquez-Perez","year":"2012","unstructured":"Velazquez-Perez L, Rodriguez-Labrada R, Alvarez-Gonzalez L, Aguilera-Rodriguez R, Alvarez Sanchez M, Canales-Ochoa N, et al. Lisuride reduces involuntary periodic leg movements in spinocerebellar ataxia type 2 patients. Cerebellum. 2012;11:1051\u20136.","journal-title":"Cerebellum"},{"key":"1504_CR11","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1007\/s11064-011-0496-0","volume":"36","author":"L Velazquez-Perez","year":"2011","unstructured":"Velazquez-Perez L, Rodriguez-Chanfrau J, Garcia-Rodriguez JC, Sanchez-Cruz G, Aguilera-Rodriguez R, Rodriguez-Labrada R, et al. Oral zinc sulphate supplementation for six months in SCA2 patients: a randomized, double-blind, placebo-controlled trial. Neurochem Res. 2011;36:1793\u2013800.","journal-title":"Neurochem Res"},{"key":"1504_CR12","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41392-023-01608-z","volume":"8","author":"V Panwar","year":"2023","unstructured":"Panwar V, Singh A, Bhatt M, Tonk RK, Azizov S, Raza AS, et al. Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease. Signal Transduct Target Ther. 2023;8:375.","journal-title":"Signal Transduct Target Ther"},{"key":"1504_CR13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4103\/2319-4170.110365","volume":"36","author":"M Wong","year":"2013","unstructured":"Wong M. Mammalian target of rapamycin (mTOR) pathways in neurological diseases. Biomed J. 2013;36:40\u201350.","journal-title":"Biomed J"},{"key":"1504_CR14","doi-asserted-by":"crossref","unstructured":"Nam Y, Moon GJ, Kim SR. Therapeutic potential of AAV1-Rheb(S16H) transduction against neurodegenerative diseases. Int J Mol Sci. 2021;22:3064.","DOI":"10.3390\/ijms22063064"},{"key":"1504_CR15","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1111\/j.1471-4159.2005.03135.x","volume":"93","author":"S Peng","year":"2005","unstructured":"Peng S, Wuu J, Mufson EJ, Fahnestock M. Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer\u2019s disease. J Neurochem. 2005;93:1412\u201321.","journal-title":"J Neurochem"},{"key":"1504_CR16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0891-0618(01)00115-6","volume":"21","author":"NB Chauhan","year":"2001","unstructured":"Chauhan NB, Siegel GJ, Lee JM. Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson\u2019s disease brain. J Chem Neuroanat. 2001;21:277\u201388.","journal-title":"J Chem Neuroanat"},{"key":"1504_CR17","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1001\/archneur.57.6.846","volume":"57","author":"C Hock","year":"2000","unstructured":"Hock C, Heese K, Hulette C, Rosenberg C, Otten U. Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas. Arch Neurol. 2000;57:846\u201351.","journal-title":"Arch Neurol"},{"key":"1504_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106023","volume":"178","author":"JG Rosa","year":"2023","unstructured":"Rosa JG, Hamel K, Soles A, Sheeler C, Borgenheimer E, Gilliat S, et al. BDNF is altered in a brain-region specific manner and rescues deficits in Spinocerebellar Ataxia Type 1. Neurobiol Dis. 2023;178:106023.","journal-title":"Neurobiol Dis"},{"key":"1504_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109831","volume":"37","author":"EAL Wozniak","year":"2021","unstructured":"Wozniak EAL, Chen Z, Paul S, Yang P, Figueroa KP, Friedrich J, et al. Cholecystokinin 1 receptor activation restores normal mTORC1 signaling and is protective to Purkinje cells of SCA mice. Cell Rep. 2021;37:109831.","journal-title":"Cell Rep."},{"key":"1504_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.neuron.2015.11.033","volume":"89","author":"C Ruegsegger","year":"2016","unstructured":"Ruegsegger C, Stucki DM, Steiner S, Angliker N, Radecke J, Keller E, et al. Impaired mTORC1-dependent expression of homer-3 influences SCA1 pathophysiology. Neuron. 2016;89:129\u201346.","journal-title":"Neuron"},{"key":"1504_CR21","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1152\/physrev.00038.2014","volume":"95","author":"J Bockaert","year":"2015","unstructured":"Bockaert J, Marin P. mTOR in Brain Physiology and Pathologies. Physiol Rev. 2015;95:1157\u201387.","journal-title":"Physiol Rev"},{"key":"1504_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/toxsci\/kfu211","volume":"143","author":"Q Zhou","year":"2015","unstructured":"Zhou Q, Liu C, Liu W, Zhang H, Zhang R, Liu J, et al. Rotenone induction of hydrogen peroxide inhibits mTOR-mediated S6K1 and 4E-BP1\/eIF4E pathways, leading to neuronal apoptosis. Toxicol Sci. 2015;143:81\u201396.","journal-title":"Toxicol Sci"},{"key":"1504_CR23","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.cellsig.2014.04.009","volume":"26","author":"Y Xu","year":"2014","unstructured":"Xu Y, Liu C, Chen S, Ye Y, Guo M, Ren Q, et al. Activation of AMPK and inactivation of Akt result in suppression of mTOR-mediated S6K1 and 4E-BP1 pathways leading to neuronal cell death in in vitro models of Parkinson\u2019s disease. Cell Signal. 2014;26:1680\u20139.","journal-title":"Cell Signal"},{"key":"1504_CR24","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1172\/JCI61332","volume":"122","author":"S Selvaraj","year":"2012","unstructured":"Selvaraj S, Sun Y, Watt JA, Wang S, Lei S, Birnbaumer L, et al. Neurotoxin-induced ER stress in mouse dopaminergic neurons involves downregulation of TRPC1 and inhibition of AKT\/mTOR signaling. J Clin Invest. 2012;122:1354\u201367.","journal-title":"J Clin Invest"},{"key":"1504_CR25","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1523\/JNEUROSCI.0590-10.2011","volume":"31","author":"C Rieker","year":"2011","unstructured":"Rieker C, Engblom D, Kreiner G, Domanskyi A, Schober A, Stotz S, et al. Nucleolar disruption in dopaminergic neurons leads to oxidative damage and parkinsonism through repression of mammalian target of rapamycin signaling. J Neurosci. 2011;31:453\u201360.","journal-title":"J Neurosci"},{"key":"1504_CR26","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/j.1471-4159.2009.06463.x","volume":"112","author":"KC Choi","year":"2010","unstructured":"Choi KC, Kim SH, Ha JY, Kim ST, Son JH. A novel mTOR activating protein protects dopamine neurons against oxidative stress by repressing autophagy related cell death. J Neurochem. 2010;112:366\u201376.","journal-title":"J Neurochem"},{"key":"1504_CR27","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nm.1912","volume":"15","author":"AH Nagahara","year":"2009","unstructured":"Nagahara AH, Merrill DA, Coppola G, Tsukada S, Schroeder BE, Shaked GM, et al. Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer\u2019s disease. Nat Med. 2009;15:331\u20137.","journal-title":"Nat Med"},{"key":"1504_CR28","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.bbapap.2007.08.015","volume":"1784","author":"L Swiech","year":"2008","unstructured":"Swiech L, Perycz M, Malik A, Jaworski J. Role of mTOR in physiology and pathology of the nervous system. Biochim Biophys Acta. 2008;1784:116\u201332.","journal-title":"Biochim Biophys Acta"},{"key":"1504_CR29","doi-asserted-by":"publisher","first-page":"17093","DOI":"10.1074\/jbc.M501253200","volume":"280","author":"Y Yu","year":"2005","unstructured":"Yu Y, Li S, Xu X, Li Y, Guan K, Arnold E, et al. Structural basis for the unique biological function of small GTPase RHEB. J Biol Chem. 2005;280:17093\u2013100.","journal-title":"J Biol Chem"},{"key":"1504_CR30","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/mt.2011.213","volume":"20","author":"SR Kim","year":"2012","unstructured":"Kim SR, Kareva T, Yarygina O, Kholodilov N, Burke RE. AAV transduction of dopamine neurons with constitutively active Rheb protects from neurodegeneration and mediates axon regrowth. Mol Ther. 2012;20:275\u201386.","journal-title":"Mol Ther"},{"key":"1504_CR31","doi-asserted-by":"crossref","unstructured":"Park N, Sharma C, Jung UJ, Kim S, Nam Y, Kim KS, et al. Mesenchymal stem cell transplantation ameliorates Ara-C-induced motor deficits in a mouse model of cerebellar ataxia. J Clin Med. 2023;12:1756.","DOI":"10.3390\/jcm12051756"},{"key":"1504_CR32","doi-asserted-by":"crossref","unstructured":"Yerger J, Cougnoux AC, Abbott CB, Luke R, Clark TS, Cawley NX, et al. Phenotype assessment for neurodegenerative murine models with ataxia and application to Niemann-Pick disease, type C1. Biol Open. 2022;11:bio059052.","DOI":"10.1242\/bio.059052"},{"key":"1504_CR33","doi-asserted-by":"crossref","unstructured":"Nam Y, Yoon D, Hong J, Kim MS, Lee TY, Kim KS, et al. Therapeutic effects of human mesenchymal stem cells in a mouse model of cerebellar ataxia with neuroinflammation. J Clin Med. 2020;9:3654.","DOI":"10.3390\/jcm9113654"},{"key":"1504_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-70390-7","volume":"10","author":"J Hong","year":"2020","unstructured":"Hong J, Yoon D, Nam Y, Seo D, Kim JH, Kim MS, et al. Lipopolysaccharide administration for a mouse model of cerebellar ataxia with neuroinflammation. Sci Rep. 2020;10:13337.","journal-title":"Sci Rep."},{"key":"1504_CR35","doi-asserted-by":"crossref","unstructured":"Guyenet SJ, Furrer SA, Damian VM, Baughan TD, La Spada AR, Garden GA. A simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia. J Vis Exp. 2010;39:1787.","DOI":"10.3791\/1787-v"},{"key":"1504_CR36","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/ana.24846","volume":"81","author":"KC Kemp","year":"2017","unstructured":"Kemp KC, Cerminara N, Hares K, Redondo J, Cook AJ, Haynes HR, et al. Cytokine therapy-mediated neuroprotection in a Friedreich\u2019s ataxia mouse model. Ann Neurol. 2017;81:212\u201326.","journal-title":"Ann Neurol"},{"key":"1504_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0491-3","volume":"9","author":"E Leem","year":"2018","unstructured":"Leem E, Kim HJ, Choi M, Kim S, Oh YS, Lee KJ, et al. Upregulation of neuronal astrocyte elevated gene-1 protects nigral dopaminergic neurons in vivo. Cell Death Dis. 2018;9:449.","journal-title":"Cell Death Dis"},{"key":"1504_CR38","doi-asserted-by":"publisher","first-page":"e440","DOI":"10.1038\/emm.2017.261","volume":"50","author":"S Kim","year":"2018","unstructured":"Kim S, Moon GJ, Oh YS, Park J, Shin WH, Jeong JY, et al. Protection of nigral dopaminergic neurons by AAV1 transduction with Rheb(S16H) against neurotoxic inflammation in vivo. Exp Mol Med. 2018;50:e440.","journal-title":"Exp Mol Med"},{"key":"1504_CR39","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s12035-014-8729-2","volume":"51","author":"JH Nam","year":"2015","unstructured":"Nam JH, Leem E, Jeon MT, Jeong KH, Park JW, Jung UJ, et al. Induction of GDNF and BDNF by hRheb(S16H) transduction of SNpc neurons: neuroprotective mechanisms of hRheb(S16H) in a model of Parkinson\u2019s disease. Mol Neurobiol. 2015;51:487\u201399.","journal-title":"Mol Neurobiol"},{"key":"1504_CR40","doi-asserted-by":"publisher","first-page":"13428","DOI":"10.1073\/pnas.1204089109","volume":"109","author":"H Tsoi","year":"2012","unstructured":"Tsoi H, Lau TC, Tsang SY, Lau KF, Chan HY. CAG expansion induces nucleolar stress in polyglutamine diseases. Proc Natl Acad Sci USA. 2012;109:13428\u201333.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1504_CR41","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s13311-023-01357-5","volume":"20","author":"M Cvetanovic","year":"2023","unstructured":"Cvetanovic M, Gray M. Contribution of glial cells to polyglutamine diseases: observations from patients and mouse models. Neurotherapeutics. 2023;20:48\u201366.","journal-title":"Neurotherapeutics"},{"key":"1504_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02801-1","volume":"20","author":"CR Edamakanti","year":"2023","unstructured":"Edamakanti CR, Mohan V, Opal P. Reactive Bergmann glia play a central role in spinocerebellar ataxia inflammation via the JNK pathway. J Neuroinflammation. 2023;20:126.","journal-title":"J Neuroinflammation"},{"key":"1504_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2024.1422442","volume":"18","author":"ZT Cui","year":"2024","unstructured":"Cui ZT, Mao ZT, Yang R, Li JJ, Jia SS, Zhao JL, et al. Spinocerebellar ataxias: from pathogenesis to recent therapeutic advances. Front Neurosci. 2024;18:1422442.","journal-title":"Front Neurosci"},{"key":"1504_CR44","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/jb\/mvi046","volume":"137","author":"K Saito","year":"2005","unstructured":"Saito K, Araki Y, Kontani K, Nishina H, Katada T. Novel role of the small GTPase Rheb: its implication in endocytic pathway independent of the activation of mammalian target of rapamycin. J Biochem. 2005;137:423\u201330.","journal-title":"J Biochem"},{"key":"1504_CR45","doi-asserted-by":"publisher","first-page":"16333","DOI":"10.1016\/S0021-9258(17)34012-7","volume":"269","author":"K Yamagata","year":"1994","unstructured":"Yamagata K, Sanders LK, Kaufmann WE, Yee W, Barnes CA, Nathans D, et al. rheb, a growth factor- and synaptic activity-regulated gene, encodes a novel Ras-related protein. J Biol Chem. 1994;269:16333\u20139.","journal-title":"J Biol Chem"},{"key":"1504_CR46","doi-asserted-by":"crossref","unstructured":"Schoneborn H, Raudzus F, Coppey M, Neumann S, Heumann R. Perspectives of RAS and RHEB GTPase signaling pathways in regenerating brain neurons. Int J Mol Sci. 2018;19:4052.","DOI":"10.3390\/ijms19124052"},{"key":"1504_CR47","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/ana.22383","volume":"70","author":"SR Kim","year":"2011","unstructured":"Kim SR, Chen X, Oo TF, Kareva T, Yarygina O, Wang C, et al. Dopaminergic pathway reconstruction by Akt\/Rheb-induced axon regeneration. Ann Neurol. 2011;70:110\u201320.","journal-title":"Ann Neurol"},{"key":"1504_CR48","doi-asserted-by":"publisher","first-page":"33979","DOI":"10.1074\/jbc.M109.095968","volume":"285","author":"S Karassek","year":"2010","unstructured":"Karassek S, Berghaus C, Schwarten M, Goemans CG, Ohse N, Kock G, et al. Ras homolog enriched in brain (Rheb) enhances apoptotic signaling. J Biol Chem. 2010;285:33979\u201391.","journal-title":"J Biol Chem"},{"key":"1504_CR49","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.molcel.2020.10.004","volume":"80","author":"Y Yao","year":"2020","unstructured":"Yao Y, Hong S, Ikeda T, Mori H, MacDougald OA, Nada S, et al. Amino acids enhance polyubiquitination of Rheb and its binding to mTORC1 by blocking lysosomal ATXN3 deubiquitinase activity. Mol Cell. 2020;80:437\u201351.e6.","journal-title":"Mol Cell"},{"key":"1504_CR50","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.1093\/hmg\/ddw242","volume":"25","author":"I Sanchez","year":"2016","unstructured":"Sanchez I, Balague E, Matilla-Duenas A. Ataxin-1 regulates the cerebellar bioenergetics proteome through the GSK3beta-mTOR pathway which is altered in Spinocerebellar ataxia type 1 (SCA1). Hum Mol Genet. 2016;25:4021\u201340.","journal-title":"Hum Mol Genet"},{"key":"1504_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119358","volume":"275","author":"S Tandon","year":"2021","unstructured":"Tandon S, Sarkar S. The S6k\/4E-BP mediated growth promoting sub-pathway of insulin signalling cascade is essential to restrict pathogenesis of poly(Q) disorders in Drosophila. Life Sci. 2021;275:119358.","journal-title":"Life Sci"},{"key":"1504_CR52","doi-asserted-by":"crossref","unstructured":"Lee JH, Lin SY, Liu JW, Lin SZ, Harn HJ, Chiou TW. n-butylidenephthalide modulates autophagy to ameliorate neuropathological progress of spinocerebellar ataxia type 3 through mTOR pathway. Int J Mol Sci. 2021;22:6339.","DOI":"10.3390\/ijms22126339"},{"key":"1504_CR53","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.nbd.2015.03.014","volume":"84","author":"M Perluigi","year":"2015","unstructured":"Perluigi M, Di Domenico F, Butterfield DA. mTOR signaling in aging and neurodegeneration: at the crossroad between metabolism dysfunction and impairment of autophagy. Neurobiol Dis. 2015;84:39\u201349.","journal-title":"Neurobiol Dis"},{"key":"1504_CR54","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3389\/fncel.2018.00509","volume":"12","author":"A Mellesmoen","year":"2018","unstructured":"Mellesmoen A, Sheeler C, Ferro A, Rainwater O, Cvetanovic M. Brain derived neurotrophic factor (BDNF) delays onset of pathogenesis in transgenic mouse model of spinocerebellar ataxia type 1 (SCA1). Front Cell Neurosci. 2018;12:509.","journal-title":"Front Cell Neurosci"},{"key":"1504_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-020-00723-0","volume":"14","author":"AS Sowa","year":"2021","unstructured":"Sowa AS, Popova TG, Harmuth T, Weber JJ, Pereira Sena P, Schmidt J, et al. Neurodegenerative phosphoprotein signaling landscape in models of SCA3. Mol Brain. 2021;14:57.","journal-title":"Mol Brain"},{"key":"1504_CR56","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.bbadis.2016.05.017","volume":"1862","author":"I Lastres-Becker","year":"2016","unstructured":"Lastres-Becker I, Nonis D, Eich F, Klinkenberg M, Gorospe M, Kotter P, et al. Mammalian ataxin-2 modulates translation control at the pre-initiation complex via PI3K\/mTOR and is induced by starvation. Biochim Biophys Acta. 2016;1862:1558\u201369.","journal-title":"Biochim Biophys Acta"},{"key":"1504_CR57","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1111\/febs.17081","volume":"291","author":"YJ Liu","year":"2024","unstructured":"Liu YJ, Wang JY, Zhang XL, Jiang LL, Hu HY. Ataxin-2 sequesters Raptor into aggregates and impairs cellular mTORC1 signaling. FEBS J. 2024;291:1795\u2013812.","journal-title":"FEBS J"},{"key":"1504_CR58","doi-asserted-by":"publisher","first-page":"8528","DOI":"10.1073\/pnas.0600497103","volume":"103","author":"K Furutani","year":"2006","unstructured":"Furutani K, Okubo Y, Kakizawa S, Iino M. Postsynaptic inositol 1,4,5-trisphosphate signaling maintains presynaptic function of parallel fiber-Purkinje cell synapses via BDNF. Proc Natl Acad Sci USA. 2006;103:8528\u201333.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1504_CR59","doi-asserted-by":"crossref","unstructured":"Lalonde R, Hernandez M, Strazielle C. BDNF and cerebellar ataxia. Curr Drug Res Rev. 2024;16:300\u20137.","DOI":"10.2174\/2589977515666230811093021"},{"key":"1504_CR60","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abh3260","volume":"8","author":"AA Cook","year":"2022","unstructured":"Cook AA, Jayabal S, Sheng J, Fields E, Leung TCS, Quilez S, et al. Activation of TrkB-Akt signaling rescues deficits in a mouse model of SCA6. Sci Adv. 2022;8:eabh3260.","journal-title":"Sci Adv"},{"key":"1504_CR61","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s12311-020-01226-3","volume":"20","author":"C Sheeler","year":"2021","unstructured":"Sheeler C, Rosa JG, Borgenheimer E, Mellesmoen A, Rainwater O, Cvetanovic M. Post-symptomatic delivery of brain-derived neurotrophic factor (BDNF) ameliorates spinocerebellar ataxia type 1 (SCA1) pathogenesis. Cerebellum. 2021;20:420\u20139.","journal-title":"Cerebellum"},{"key":"1504_CR62","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/j.1440-1789.2012.01302.x","volume":"32","author":"M Takahashi","year":"2012","unstructured":"Takahashi M, Ishikawa K, Sato N, Obayashi M, Niimi Y, Ishiguro T, et al. Reduced brain-derived neurotrophic factor (BDNF) mRNA expression and presence of BDNF-immunoreactive granules in the spinocerebellar ataxia type 6 (SCA6) cerebellum. Neuropathology. 2012;32:595\u2013603.","journal-title":"Neuropathology"},{"key":"1504_CR63","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0896-6273(00)80938-1","volume":"19","author":"PM Schwartz","year":"1997","unstructured":"Schwartz PM, Borghesani PR, Levy RL, Pomeroy SL, Segal RA. Abnormal cerebellar development and foliation in BDNF-\/- mice reveals a role for neurotrophins in CNS patterning. Neuron. 1997;19:269\u201381.","journal-title":"Neuron"},{"key":"1504_CR64","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.expneurol.2011.11.043","volume":"233","author":"Y Huang","year":"2012","unstructured":"Huang Y, Ko H, Cheung ZH, Yung KK, Yao T, Wang JJ, et al. Dual actions of brain-derived neurotrophic factor on GABAergic transmission in cerebellar Purkinje neurons. Exp Neurol. 2012;233:791\u20138.","journal-title":"Exp Neurol"},{"key":"1504_CR65","doi-asserted-by":"publisher","first-page":"9092","DOI":"10.1073\/pnas.92.20.9092","volume":"92","author":"HT Mount","year":"1995","unstructured":"Mount HT, Dean DO, Alberch J, Dreyfus CF, Black IB. Glial cell line-derived neurotrophic factor promotes the survival and morphologic differentiation of Purkinje cells. Proc Natl Acad Sci USA. 1995;92:9092\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1504_CR66","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/j.1460-9568.1994.tb00596.x","volume":"6","author":"L Larkfors","year":"1994","unstructured":"Larkfors L, Lindsay RM, Alderson RF. Ciliary neurotrophic factor enhances the survival of Purkinje cells in vitro. Eur J Neurosci. 1994;6:1015\u201325.","journal-title":"Eur J Neurosci"},{"key":"1504_CR67","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/0169-328X(95)00250-V","volume":"36","author":"JF Poduslo","year":"1996","unstructured":"Poduslo JF, Curran GL. Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF. Brain Res Mol Brain Res. 1996;36:280\u20136.","journal-title":"Brain Res Mol Brain Res"},{"key":"1504_CR68","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/ana.410350206","volume":"35","author":"F Dittrich","year":"1994","unstructured":"Dittrich F, Thoenen H, Sendtner M. Ciliary neurotrophic factor: pharmacokinetics and acute-phase response in rat. Ann Neurol. 1994;35:151\u201363.","journal-title":"Ann Neurol"},{"key":"1504_CR69","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.neuro.24.1.677","volume":"24","author":"EJ Huang","year":"2001","unstructured":"Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci. 2001;24:677\u2013736.","journal-title":"Annu Rev Neurosci"},{"key":"1504_CR70","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.omtm.2019.11.012","volume":"17","author":"DL Haggerty","year":"2020","unstructured":"Haggerty DL, Grecco GG, Reeves KC, Atwood B. Adeno-associated viral vectors in neuroscience research. Mol Ther Methods Clin Dev. 2020;17:69\u201382.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"1504_CR71","doi-asserted-by":"crossref","unstructured":"Witteveen I, Balmer T. Comparative analysis of six adeno-associated viral vector serotypes in mouse inferior colliculus and cerebellum. eNeuro. 2024;11:0391\u201324.","DOI":"10.1523\/ENEURO.0391-24.2024"},{"key":"1504_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40111-5","volume":"14","author":"FGC Blot","year":"2023","unstructured":"Blot FGC, White JJ, van Hattem A, Scotti L, Balaji V, Adolfs Y, et al. Purkinje cell microzones mediate distinct kinematics of a single movement. Nat Commun. 2023;14:4358.","journal-title":"Nat Commun"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01504-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01504-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01504-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T19:04:50Z","timestamp":1751051090000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01504-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":72,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1504"],"URL":"https:\/\/doi.org\/10.1038\/s41401-025-01504-y","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,3]]},"assertion":[{"value":"15 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}